Loading clinical trials...

Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers | Clinical Trials | Clareo Health

COMPLETEDNCT02837705

Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers

The human Prion diseases can be classified into sporadic, acquired and inherited forms. Inherited forms usually manifest in higher age so there have to be factors preventing Prion propagation in young...

Lead sponsor: University of Zurich•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment213

Start dateSep 2015

Last updatedMay 24, 2023

Condition

Prion Diseases

Locations shown

UCSF Memory and Aging Center

San Francisco, California

Medical University Graz

Graz

University Medical Center Göttingen

Göttingen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 24, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions